|
Cell Applications Inc
cadmec Cadmec, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/us07153678-5335-0-7?v=Cell+Applications+Inc Average 96 stars, based on 1 article reviews
cadmec - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
Poietics Inc
human cd34+ cd38− cells Human Cd34+ Cd38− Cells, supplied by Poietics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pm20045756-32-4-23?v=Poietics+Inc Average 90 stars, based on 1 article reviews
human cd34+ cd38− cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
PROVITRO GmbH
human foreskin microvascular endothelial cells Human Foreskin Microvascular Endothelial Cells, supplied by PROVITRO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pm20048211-65-0-5?v=PROVITRO+GmbH Average 90 stars, based on 1 article reviews
human foreskin microvascular endothelial cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Innoprot Inc
human microvascular endothelial cells hmec Human Microvascular Endothelial Cells Hmec, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pmc06754430-63-0-5?v=Innoprot+Inc Average 93 stars, based on 1 article reviews
human microvascular endothelial cells hmec - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
ScienCell
human cardiac microvascular endothelial cells (hcmecs) Human Cardiac Microvascular Endothelial Cells (Hcmecs), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pm37052764-38-5-16?v=ScienCell Average 90 stars, based on 1 article reviews
human cardiac microvascular endothelial cells (hcmecs) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ScienCell
endothelial cells human adipose microvascular ec (hamvec) ![]() Endothelial Cells Human Adipose Microvascular Ec (Hamvec), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pmc07391264-78-0-10?v=ScienCell Average 90 stars, based on 1 article reviews
endothelial cells human adipose microvascular ec (hamvec) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ScienCell
human microvascular endothelial cells ![]() Human Microvascular Endothelial Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pmc07767198-81-0-7?v=ScienCell Average 90 stars, based on 1 article reviews
human microvascular endothelial cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
PELOBIOTECH GmbH
human microvascular endothelial cells ![]() Human Microvascular Endothelial Cells, supplied by PELOBIOTECH GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/us11717476-236-1-10?v=PELOBIOTECH+GmbH Average 90 stars, based on 1 article reviews
human microvascular endothelial cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ScienCell
human intestinal microvascular endothelial cells ![]() Human Intestinal Microvascular Endothelial Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/us11807871-549-0-9?v=ScienCell Average 90 stars, based on 1 article reviews
human intestinal microvascular endothelial cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ATCC
murine microvascular endothelial cells mec ![]() Murine Microvascular Endothelial Cells Mec, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/10__1158_slash_1535___7163__mct___11___0402-41-0-8?v=ATCC Average 99 stars, based on 1 article reviews
murine microvascular endothelial cells mec - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
ATCC
human microvascular endothelial cells ![]() Human Microvascular Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pm20833953-88-0-8?v=ATCC Average 97 stars, based on 1 article reviews
human microvascular endothelial cells - by Bioz Stars,
2026-08
97/100 stars
|
Buy from Supplier |
|
Cell Systems Corporation
human cerebral artery microvascular endothelial cells ![]() Human Cerebral Artery Microvascular Endothelial Cells, supplied by Cell Systems Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pooled+human+dermal+mvec/pmc02845943-79-6-11?v=Cell+Systems+Corporation Average 90 stars, based on 1 article reviews
human cerebral artery microvascular endothelial cells - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Arteriosclerosis, thrombosis, and vascular biology
Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction
doi: 10.1161/ATVBAHA.119.312826
Figure Lengend Snippet: A: Averaged curves and quantitation of trans- endothelial electrical resistance (TER) of untreated or PIC treated HAMVECs for 24 hours. TER was monitored in confluent cell monolayers for 24 hours using an electric cell substrate impedance sensor instrument (ECSIS). Data was quantitated using area under curve (AUC) and the results from three different experiments performed in triplicate were presented as average±SD. B: Averaged curves showing the “wound closure” kinetics of untreated and PIC treated cells for 24 hours prior to application of the wound. Wound closure was expressed as speed of closure (μm/hr). Data represent average from three independent experiments performed in duplicate. C: Representative micrographs and quantitation of HAMVEC proliferation using BrDU incorporation assay. Untreated or PIC treated cells for either 1 or 6 days were plated on fibronectin-coated chamber slides and incubated with BrDU for 24 hours. Cell nuclei are stained blue with DAPI. Nuclei of the proliferating cells are stained green using a FITC-labeled BrDU antibody. Overlapping images of the same field show both proliferating cells (light blue nuclei) and non-proliferating cells (dark blue, DAPI only). Magnification is 200x (Scale Bar=50-μm). Quantitation was done by calculation of % of BrDU stained cells to total cells. Data is expressed as % proliferation of PIC treated cells compared to control cells for each of the 1hr and 6 hr time points ± SD. For each experimental condition, three independent experiments with cells from three independent donors were performed in duplicate and 3 different areas for each replicate were imaged and counted. Cells between passages 4–7 were used in all experiments. Statistical analysis was performed using paired Student’s t-test between PIC and control samples.
Article Snippet:
Techniques: Quantitation Assay, BrdU Incorporation Assay, Incubation, Staining, Labeling, Control
Journal: Arteriosclerosis, thrombosis, and vascular biology
Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction
doi: 10.1161/ATVBAHA.119.312826
Figure Lengend Snippet: HAMVEC with or without PIC treatment for 1day (A) or 6 days (B) were labeled with calcein, seeded in growth factor reduced Matrigel coated plates and incubated for 6 hours before imaging. Representative micrographs (top panels) show reduced formation of branches and reduced tubule length in PIC treated cells, which were totally blunted after 6 days of treatment; Magnification 40x (Scale Bar=200-μm). Angiogenesis was quantified as average numbers of branches and average tubule lengths in three independent experiments performed in triplicate. Three different pictures for each replicate were analyzed using the Image J Angiogenesis software and data was represented as average ±SD. ND = not detectable. Data represents average of three independent experiments performed in duplicate using EC from 3 individual donors on passages 4–7. Data is expressed as the mean+/−SD. Comparisons were performed using paired Student’s t-test.
Article Snippet:
Techniques: Labeling, Incubation, Imaging, Software
Journal: Arteriosclerosis, thrombosis, and vascular biology
Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction
doi: 10.1161/ATVBAHA.119.312826
Figure Lengend Snippet: A: Oxygen consumption rate (OCR) was utilized to assess endothelial metabolism in HAMVECs stimulated with PICs for 6 days using a Mitochondrial Stress Test. Cells were seeded into Seahorse XFe24 plates at 50,000 cells/well and allowed to attach and grow for 24 hours until they reached 70–80%confluence. Respiration data was normalized to total cellular protein. B: Proton efflux rate due to glycolysis (GlycoPER) was measured using the glycolysis stress kit in cells seeded in similar conditions as above. Data is normalized to total protein. C: Fatty acid oxidation was measured using palmitate-BSA as a substrate according to a protocol detailed in Methods section. For this assays cells were allowed to reach 100% confluence. Etomoxir (4uM) was used as a positive control for inhibition of beta-oxidation D: Phenogram showing extracellular acidification and oxygen consumption; E: Gene expression of Cpt1, Cpt2 and Acly was measured in control and PIC-treated HAMVEC for 6 days by real-time PCR; F: Western blotting and semi-quantitation of CPT1a expression in HAMVEC treated with PIC for 6 days and untreated controls.G: miR-155–5p measured by real-time PCR in PIC-treated cells for 6 days compared to controls. H: Diagram showing proposed scenario involving down regulation of CPT1, and ACLY via miR-155–5p leading to an overall reduction in HAMVEC metabolism in response to PIC treatment. Data represents average of three independent experiments performed in duplicate using EC from 3 individual donors on passages 4–8. Data is expressed as the mean+/−SD.
Article Snippet:
Techniques: Positive Control, Inhibition, Gene Expression, Control, Real-time Polymerase Chain Reaction, Western Blot, Quantitation Assay, Expressing
Journal: Arteriosclerosis, thrombosis, and vascular biology
Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction
doi: 10.1161/ATVBAHA.119.312826
Figure Lengend Snippet: A: Nanoparticle size distribution of extracellular vesicles (EV) isolated from untreated control cells (EV-C) and from PIC-treated cells (EV-PIC) shows an average peak size of 140–150-nm for both EV preparations. B: Representative micrographs of negative staining electron microscopy of EV-PIC and EV-C confirms the presence of EVs in the size range calculated by nanoparticle tracking analysis in both preparations; C: Nanosight analysis shows a 3-fold higher number of EV-PIC/cell compared to EV-C. This difference was consistent across 12 different EV preparations from control and PIC treated cells. D: Western blot showing expression of various markers in control and PIC treated cells and in EV-C and EV-PIC extracellular vesicles. Exosomal markers syntenin-1 and CD9 are enriched in both EV-PIC and EV-C compared to parent cells and CD63 and HSP70 were present in both EV preparations; calnexin (microsomal marker) and LAMP1 (lysosomal marker) were not detectable in either one of the EV preparations. E: diagram showing experimental protocol for EV production, isolation and incubation with recipient cells. F: EV-PIC and EV-C were labeled with the fluorescent lipophilic dye Vybrant DiO and incubated with EC overnight; representative micrographs show uptake by HAMVEC at 37°C and show dramatic reduction of uptake at 22°C, suggesting an energy dependent uptake mechanism; magnification 100x (Scale Bar=100-μm); higher magnification inset shows the peri-nuclear distribution of the labeled EVs. G: Quantitative analysis of EV uptake using flow cytometry of the HAMVEC cells after 24 h incubation with labeled EVs. Representative flow cytometry plots show the background control that was subtracted from the uptake data (left panel); negative control (center left) and EV-PIC and EV-C representative uptake plots. Concentration dependent uptake was determined in pilot experiments. Results shown here are from incubation of 105 cells with 1010 EV-C or EV-PIC for 24 hours. Data is expressed as mean of % cell uptake ± SD and shows no difference between uptake of EV-C and EV-PIC. Results are from 3 independent experiments, performed in duplicate, using cells from 3 separate donors, on passages 4–5.
Article Snippet:
Techniques: Isolation, Control, Negative Staining, Electron Microscopy, Western Blot, Expressing, Marker, Incubation, Labeling, Flow Cytometry, Negative Control, Concentration Assay
Journal: Arteriosclerosis, thrombosis, and vascular biology
Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction
doi: 10.1161/ATVBAHA.119.312826
Figure Lengend Snippet: HAMVEC were incubated for 24 hours with either EV-C, EV-PIC or were left untreated. Following treatment, cells were labeled with calcein, seeded in growth factor reduced matrigel coated plates and incubated for 6 hours before imaging. Representative micrographs (top panels) showing reduced formation of branches and reduced tubule length in HAMVEC treated with EV-PIC compared to untreated cells; Magnification 40x (Scale Bar=200-μm). Treatment with EV-PIC severely impaired tube network parameters compared to untreated control cells and EV-C treated cells. Angiogenesis was quantified in three independent experiments performed in triplicate. Three different pictures for each replicate were analyzed using the Image J Angiogenesis Analyzer software and data was represented as average ±SD. B: Oxygen consumption rate (OCR) was utilized to assess endothelial metabolism in cells treated with EV-C or EV-PIC using a Mitochondrial Stress Test. Cells were seeded into Seahorse XFe24 plates and allowed to attach and grow for 24 hours until they reached 70–80% confluence . Respiration data was normalized to total cellular protein. B: Proton efflux rate due to glycolysis (GlycoPER) was measured using the glycolysis stress kit in cells seeded in similar conditions as above. Data is normalized to total protein. C: Fatty acid oxidation was measured using palmitate-BSA as a substrate according to a protocol detailed in Methods section. For this assays cells were allowed to reach 100% confluence. Etomoxir (Eto) (4uM) was used as a positive control for inhibition of beta-oxidation Data represents average of three independent experiments performed in duplicate on cells from 3 individual donors on passages 4–6 and are expressed as the mean+/−SD.
Article Snippet:
Techniques: Incubation, Labeling, Imaging, Control, Software, Positive Control, Inhibition
Journal: International Journal of Molecular Sciences
Article Title: Vasa Vasorum Lumen Narrowing in Brain Vascular Hyalinosis in Systemic Hypertension Patients Who Died of Ischemic Stroke
doi: 10.3390/ijms21249611
Figure Lengend Snippet: Studies of cultured human microvascular endothelial cells. ( A ) TEM images of the control cells and cells exhibiting the adrenaline-induced formation of endocytic vesicles. Cells were treated with adrenaline at 10 μM for 4 h. Magnifications, ×13,000. ( B ) siRNA knockdown of SNX9 inhibits the adrenaline-induced bulge formation. Cells were treated with siRNA for 2 days and then with adrenaline at 10 μM for 4 h. Cells were observed under light microscopy. Arrows indicate the bulge formation. Magnifications, ×400. ( C ) Immunofluorescence staining of actin in untreated control and cells treated with adrenaline (10 μM; 4 h). The arrow indicates the reorganization of actin filaments. Magnifications, ×1000. ( D ) Adrenaline promotes SNX9–N-WASp interactions. Cells were treated with 10 μM adrenaline for 0, 1 or 2 h. Cell lysates were subjected to immunoprecipitation (IP) with mouse SNX9 IgG followed by Western blotting (WB) with rabbit N-WASp IgG.
Article Snippet:
Techniques: Cell Culture, Control, Knockdown, Light Microscopy, Immunofluorescence, Staining, Immunoprecipitation, Western Blot
Journal: Molecular Pharmacology
Article Title: A Dietary Agonist of Transient Receptor Potential Cation Channel V3
Elicits Endothelium-Dependent Vasodilation
doi: 10.1124/mol.109.060715
Figure Lengend Snippet: Carvacrol stimulates TRPV3 cation currents in cerebral artery endothelial cells A, representative whole-cell currents recorded from human microvascular cerebral artery endothelial cells during voltage ramps from −100 to +100 mV. Current density is shown for cells under baseline conditions (B) and after first (1), second (2), and third (3) application of carvacrol (100 μM). B, summary data demonstrating sensitization of the carvacrol-induced current (n = 6). C, summary data showing the effects of the TRPA1 antagonist HC-030031 (HC, 3 μM) and the TRPV1–4 blocker RuR (10 μM) on carvacrol-induced currents recorded from cerebral artery endothelial cells; n = 5 for HC-030031, n = 4 for ruthenium red. Current magnitude was normalized to peak carvacrol-induced currents. *, P ≤ 0.05 versus control (C).
Article Snippet: Carvacrol-activated currents were recorded from human
Techniques: Control